Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor

Smita S. Patel(Merck & Co., Inc., Rahway, NJ, USA (United States)), Stephen B. Freedman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kerry L. Chapman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Frances Emms(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alan E. Fletcher(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mick Knowles(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rosemarie Marwood(Merck & Co., Inc., Rahway, NJ, USA (United States)), George McAllister(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jan Myers(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shil Patel(Merck & Co., Inc., Rahway, NJ, USA (United States)), Neil R. Curtis(Merck & Co., Inc., Rahway, NJ, USA (United States)), Janusz J. Kulagowski(Merck & Co., Inc., Rahway, NJ, USA (United States)), Paul D. Leeson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mark P. Ridgill(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mike Graham(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven Matheson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Denise Rathbone(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alan P. Watt(Merck & Co., Inc., Rahway, NJ, USA (United States)), Linda J. Bristow(Merck & Co., Inc., Rahway, NJ, USA (United States)), N.M.J. Rupniak(Merck & Co., Inc., Rahway, NJ, USA (United States)), Elizabeth Baskin(Merck & Co., Inc., Rahway, NJ, USA (United States)), Joseph J. Lynch(Merck & Co., Inc., Rahway, NJ, USA (United States)), C I Ragan(Merck & Co., Inc., Rahway, NJ, USA (United States))
Journal of Pharmacology and Experimental Therapeutics
November 1, 1997
Cited by 166

Abstract


Related Papers

No related papers found

Powered by citation graph analysis